Stocks / Pharmaceuticals
NAMSPharmaceuticals
NewAmsterdam Pharma Company N.V.
$22.001d +4.8%5d +0.6%settled close · 2026-09-17
Mkt cap $3.5B (3/25)β 0.9552w $21–40Shares 115.0MInd. Pharmaceutical PreparationsNasdaq since 2022Emp. 100HQ Narrden, P7newamsterdampharma.com
Who’s talkingIdea Scout · free
Who’s talking about NAMS
No tracked investor commentary on NAMS yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 3 Nov 2026 before the open
Confirmed date · consensus EPS -0.52. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where NAMS’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 13 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-17 | ||||||
| 2026-09-08 | ||||||
| 2026-08-28 | ||||||
| 2026-08-25 | ||||||
| 2026-08-19 | ||||||
| 2026-08-13 | ||||||
| 2026-08-12 | ||||||
| 2026-07-09 | ||||||
| 2026-07-06 | ||||||
| 2026-06-23 | ||||||
| 2026-06-22 | ||||||
| 2026-05-20 | ||||||
| 2026-05-14 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
NAMS is in this morning’s Brief.
Get The Brief — $20/mo →